Pneumococcal Polysaccharide Powder Type 14 (US Type 14)
81-X ™
Purified pneumococcal polysaccharide type 14 is manufactured by Pfizer, Inc., for small-quantity distribution by ATCC. The pneumococcal powder type 14 is a component of the current 13-valent vaccine against Streptococcus pneumoniae.
The pneumococcal polysaccharide type 14 can be used to assay for type-specific antibodies, research immune responses, and study immunodeficiencies.